Dupont Jakob 4
4 · Bolt Biotherapeutics, Inc. · Filed May 5, 2025
Insider Transaction Report
Form 4
Dupont Jakob
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-05-01+20,000→ 20,000 totalExercise: $0.35Exp: 2035-04-30→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/6th of the Shares will vest upon the Reporting Person completing each month of continuous service following May 1, 2025.